Syndax Pharmaceuticals, Inc.

SNDX

$18.20

Name : Syndax Pharmaceuticals, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $1,625,207,040.00

EPSttm : -2.51

Syndax Pharmaceuticals, Inc.

$18.20

1.28%

$0.23

SNDX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

25.46

Margin Of Safety %

Put/Call OI Ratio

0.2

EPS Next Q Diff

0.12

EPS Last/This Y

1.36

EPS This/Next Y

1.12

Price

18.19

Target Price

37.55

Analyst Recom

1.08

Performance Q

-14.59

Upside

-584.6%

Beta

0.43

Ticker: SNDX

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	SNDX	19.54	0.26	1.01	14304
2026-08-31	SNDX	19.3	0.28	0.01	14908
2026-09-02	SNDX	20.8	0.27	0.05	15323
2026-09-03	SNDX	20.69	0.29	0.03	14501
2026-09-04	SNDX	20.57	0.31	0.93	13860
2026-09-08	SNDX	19.95	0.31	0.05	13830
2026-09-09	SNDX	19.83	0.29	0.01	14624
2026-09-10	SNDX	18.83	0.28	0.06	15136
2026-09-11	SNDX	18.19	0.27	0.01	16489
2026-09-14	SNDX	18.34	0.27	0.34	16207
2026-09-15	SNDX	18.09	0.27	0.40	16205
2026-09-16	SNDX	17.28	0.27	0.24	16253
2026-09-17	SNDX	17.66	0.26	0.52	16283
2026-09-18	SNDX	17.62	0.25	0.85	15809
2026-09-21	SNDX	18.06	0.18	0.14	13501
2026-09-22	SNDX	18.19	0.18	2.24	13522
2026-09-23	SNDX	17.65	0.20	0.09	13876
2026-09-24	SNDX	17.99	0.20	0.42	14094
2026-09-25	SNDX	18.19	0.20	0.46	14437
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	SNDX	19.58	32.8	-	-1.93
2026-08-31	SNDX	19.29	32.8	-	-1.93
2026-09-01	SNDX	20.10	32.8	-	-1.93
2026-09-02	SNDX	20.79	32.8	-	-1.93
2026-09-03	SNDX	20.69	32.8	-	-1.93
2026-09-04	SNDX	20.57	32.8	-	-1.93
2026-09-08	SNDX	19.95	32.8	-	-1.93
2026-09-09	SNDX	19.84	32.8	-	-1.93
2026-09-10	SNDX	18.83	32.8	-	-1.93
2026-09-11	SNDX	18.19	32.8	-	-1.93
2026-09-14	SNDX	18.33	32.8	-	-1.93
2026-09-15	SNDX	18.10	32.8	-	-1.93
2026-09-16	SNDX	18.10	32.8	-	-1.93
2026-09-17	SNDX	17.65	32.8	-	-1.93
2026-09-18	SNDX	17.62	32.8	-	-1.93
2026-09-21	SNDX	18.05	32.8	-	-1.93
2026-09-22	SNDX	18.19	32.8	-	-1.93
2026-09-23	SNDX	17.65	32.8	-	-1.93
2026-09-24	SNDX	17.99	32.8	-	-1.93
2026-09-25	SNDX	18.19	32.8	-	-1.93
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	SNDX	-1.26	10.92	28.29
2026-08-31	SNDX	-1.26	10.91	28.24
2026-09-01	SNDX	-1.27	10.91	28.24
2026-09-02	SNDX	-1.27	10.91	28.24
2026-09-03	SNDX	-1.27	10.91	28.24
2026-09-04	SNDX	-1.27	10.91	28.24
2026-09-08	SNDX	-1.27	10.80	28.24
2026-09-09	SNDX	-1.27	10.80	28.24
2026-09-10	SNDX	-1.27	10.80	28.24
2026-09-11	SNDX	-1.27	10.80	26.74
2026-09-14	SNDX	-1.28	10.79	26.72
2026-09-15	SNDX	-1.28	10.79	26.72
2026-09-16	SNDX	-1.28	10.79	26.72
2026-09-17	SNDX	-1.28	10.79	26.72
2026-09-18	SNDX	-1.28	10.79	26.72
2026-09-21	SNDX	-1.28	10.78	26.72
2026-09-23	SNDX	-1.28	10.78	26.72
2026-09-24	SNDX	-1.28	10.78	26.72
2026-09-25	SNDX	-1.28	10.78	25.46
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.55

Avg. EPS Est. Current Quarter

-0.47

Avg. EPS Est. Next Quarter

-0.43

Insider Transactions

-1.28

Institutional Transactions

10.78

Beta

0.43

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

39.1

Max Drawdown 5-Year %

-69.9

Target Price

37.55

P/E

Forward P/E

PEG

P/S

6.44

P/B

107.46

P/Free Cash Flow

EPS

-2.52

Average EPS Est. Cur. Y

-1.93

EPS Next Y. (Est.)

-0.82

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-87.52

Relative Volume

0.77

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.25

EBIT Estimation

◆ SNDX Healthcare

$18.20

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

19/25

Volume

9/15

Valuation

12/20

TP/AR

2/10

Options

7/10

RSI

43.4

Range 1M

29.2%

Sup Dist

4.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

23/30

Estimates

0/20

Inst/Vol

6/15

Options

10/10

EPS Yr

39.8%

EPS NY

59.8%

52W%

41.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +106.3% upside

Quality

6/30

Valuation

14/30

Growth

17/25

Stability

6/10

LT Trend

0/5

Upside

+106.3%

Quality

SNDX — P/E HistoricalBiotechnology

Syndax Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 298

Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory R/R acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease. The company is also developing revumenib for the treatment of R/R acute myeloid leukemia (AML) with a nucleophosmin 1 mutation (mNPM1) and in combination with standard-of-care agents in mNPM1 AML or KMT2Ar acute leukemia, as well as for metastatic colorectal cancer; axatilimab to treat idiopathic pulmonary fibrosis; and Entinostat, a Class 1 HDAC inhibitor. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in New York, New York.

SNDX

Latest News

—

Caricamento notizie per SNDX…

stock quote shares SNDX – Syndax Pharmaceuticals, Inc. Stock Price stock today

news today SNDX – Syndax Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch SNDX – Syndax Pharmaceuticals, Inc. yahoo finance google finance

stock history SNDX – Syndax Pharmaceuticals, Inc. invest stock market

stock prices SNDX premarket after hours

ticker SNDX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SNDX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y